Your browser doesn't support javascript.
loading
Developing a far-red fluorogenic beta-galactosidase probe for senescent cell imaging and photoablation.
Lee, Seung Koo; Shen, Zhenhua; Han, Myung Shin; Tung, Ching-Hsuan.
Afiliação
  • Lee SK; Department of Radiology, Molecular Imaging Innovations Institute, Weill Cornell Medicine New York NY 10021 USA cht2018@med.cornell.edu.
  • Shen Z; Department of Radiology, Molecular Imaging Innovations Institute, Weill Cornell Medicine New York NY 10021 USA cht2018@med.cornell.edu.
  • Han MS; Department of Radiology, Molecular Imaging Innovations Institute, Weill Cornell Medicine New York NY 10021 USA cht2018@med.cornell.edu.
  • Tung CH; Department of Radiology, Molecular Imaging Innovations Institute, Weill Cornell Medicine New York NY 10021 USA cht2018@med.cornell.edu.
RSC Adv ; 12(8): 4543-4549, 2022 Feb 03.
Article em En | MEDLINE | ID: mdl-35425504
ABSTRACT
A methylene blue (MB)-based beta-galactosidase (ß-gal) activatable molecule, Gal-MB, was developed for senescence imaging and light-triggered senolysis. When in contact with LacZ ß-gal or senescence-associated ß-gal (SA-ß-gal), the photoinsensitive Gal-MB becomes fluorescent. Gal-MB also offered selective phototoxicity toward LacZ ß-gal expressing cells and drug-induced senescent cells, which express SA-ß-gal, after light illumination at 665 nm.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article